THX Pharma Société Anonyme (EPA:ALTHX)
France · Delayed Price · Currency is EUR 3.200
-0.130 (-3.90%)
Oct 22, 2026, 5:35 PM CEST
EPA:ALTHX Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Revenue | 0.02 | 0.81 | 2.28 | 0.3 | 0.41 | 0 |
| 3.26 | 0.81 | 2.28 | 0.3 | 0.41 | 0 | |
Revenue Growth | 271.61% | -64.70% | 670.55% | -28.58% | 68819.93% | -99.80% |
Cost of Revenue | 3.42 | 2.23 | 2.62 | 4.94 | 3.78 | 5.47 |
Gross Profit | -0.16 | -1.43 | -0.33 | -4.64 | -3.36 | -5.47 |
Selling, General & Admin | 2.68 | 1.86 | 2.15 | 2.7 | 3.31 | 2.78 |
Other Operating Expenses | 0.68 | 0.65 | 0.05 | 0.05 | -0.75 | 0.07 |
Operating Expenses | 3.48 | 2.62 | 2.29 | 3 | 2.9 | 4.05 |
Operating Income | -3.65 | -4.05 | -2.63 | -7.64 | -6.26 | -9.51 |
Interest Expense | -0.1 | -0.1 | -0.07 | -0.08 | -0.09 | -0.11 |
Interest & Investment Income | 0.25 | 0.11 | 0.1 | 0.12 | 0 | 0.01 |
Earnings From Equity Investments | 0.04 | 0.04 | - | - | - | - |
Currency Exchange Gain (Loss) | -0.01 | -0 | 0 | -0 | 0.03 | 0.04 |
Other Non Operating Income (Expenses) | -0 | 0 | -0 | 0.02 | 0.01 | - |
EBT Excluding Unusual Items | -3.46 | -4 | -2.59 | -7.58 | -6.29 | -9.58 |
Gain (Loss) on Sale of Investments | -0.01 | 0 | -0.04 | -0.05 | -0.12 | -0.33 |
Asset Writedown | - | - | - | - | -0.77 | - |
Other Unusual Items | -0.04 | - | 0.1 | - | - | - |
Pretax Income | -3.52 | -4 | -2.53 | -7.63 | -7.19 | -9.91 |
Income Tax Expense | -1.49 | -1 | -0.77 | -0.8 | -0.62 | -1.76 |
Net Income | -2.03 | -3 | -1.77 | -6.83 | -6.57 | -8.15 |
Net Income to Common | -2.03 | -3 | -1.77 | -6.83 | -6.57 | -8.15 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 15 | 14 | 9 | 8 | 5 | 5 |
Shares Outstanding (Diluted) | 15 | 14 | 9 | 8 | 5 | 5 |
Shares Change | 54.07% | 61.62% | 10.03% | 45.13% | 6.42% | 22.91% |
EPS (Basic) | -0.14 | -0.22 | -0.21 | -0.88 | -1.23 | -1.62 |
EPS (Diluted) | -0.14 | -0.22 | -0.21 | -0.88 | -1.23 | -1.62 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 8.68 | -1.14 | -3.33 | -6.41 | -5.41 | -6.16 |
Free Cash Flow Per Share | 0.60 | -0.08 | -0.39 | -0.83 | -1.01 | -1.23 |
Gross Margin | -5.04% | -177.00% | -14.61% | - | - | - |
Operating Margin | -112.00% | -502.29% | -115.02% | -2579.44% | -1508.17% | -1580101.00% |
Profit Margin | -62.35% | -372.38% | -77.31% | -2304.16% | -1582.85% | -1353889.37% |
Free Cash Flow Margin | 266.70% | -141.57% | -145.99% | -2162.21% | -1305.10% | -1023241.53% |
EBITDA | -3.53 | -3.94 | -2.53 | -7.39 | -5.93 | -8.35 |
EBITDA Margin | -108.36% | - | -110.81% | - | - | - |
D&A For EBITDA | 0.12 | 0.11 | 0.1 | 0.26 | 0.33 | 1.16 |
EBIT | -3.65 | -4.05 | -2.63 | -7.64 | -6.26 | -9.51 |
EBIT Margin | -112.00% | - | -115.02% | - | - | - |
Revenue as Reported | 3.25 | 0.81 | 2.3 | 0.32 | 1.25 | 0.03 |
Advertising Expenses | - | 0.11 | 0.06 | 0.1 | 0.15 | 0.09 |